Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company that develops products to prevent and treat infectious and inflammatory diseases and cancer. Our clinical-stage product c...
Dynavax Technologies Corporation is a clinical-stage biopharmaceutical company that develops products to prevent and treat infectious and inflammatory diseases and cancer. Our clinical-stage product candidates include: Phase 3 HEPLISAV-B â„¢ Adult Hepatitis B Vaccine Phase 1/2 Cancer Immunotherapy Phase 2 Asthma Therapy - Partnered with AstraZeneca In Europe, Dynavax manufactures Hepatitis B surface antigen for HEPLISAV-B.
Public Symbol
DVAX
Founded Year
1996
Organization Website
dynavax.com
Organization Languages
English
Organization Revenue
4000
Alexa Ranking
544098
Current Technologies
mimecast
office 365
rackspace
google maps
google analytics
bootstrap framework
apache
omniture adobe
google font api
asp net
mobile friendly
Job Functions
Engineering
Operations
Information Technology
Finance
Consulting
Accounting
Business Development
Human Resources
Marketing
Legal
Support
Sales
Media And Commmunication
Education
biotechnology
pharmaceuticals
medical
Lauryn Lawson's Work History and Education
Dynavax Technologies
Administrative Assistant to General Counsel, VP of HR and VP of Corporate Strategy